The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|September 15, 2020
Vizibl Enters Phase I Partnership with Sanofi
Author(s)Pharmaceutical Technology Editors
Vizibl and Sanofi have entered into a Phase I partnership to streamline processes around supplier management.
Advertisement
Software-as-a-service (SaaS) platform provider, Vizibl, has announced, in a Sept. 16, 2020 press release, the formation of a Phase I partnership with Sanofi to streamline processes around supplier management.
The partnership will see Sanofi’s key supplier management teams use Vizibl’s Supplier Collaboration and Innovation (SC&I) solution to build more strategic relationships with top tier suppliers. Additionally, Sanofi will use Vizibl to capture continuous improvement and innovation opportunities from suppliers as a part of its supplier nurture program.
“In today’s hyper-dynamic environment, Vizibl enables Sanofi to bring transparency to its supplier relationships and optimize its strategic versus run-the-business activities to make better investment decisions and deliver outstanding growth and value opportunities,” said Mark Perera, CEO at Vizibl, in the press release. “We look forward to changing the world together with Sanofi and cannot wait to see the great results that come out of this relationship for Sanofi’s customers.”
Source:
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
2
AI Formulation: Regulators Want Data
3
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
4
PharmTech Weekly Roundup—October 23, 2026: CMC Considerations, Rare Disease Development, Standards Harmonization
5